Top Markets
Coin of the day
Kringle Pharma, Inc. Kringle Pharma, Inc.

Kringle Pharma, Inc.

4884
Rank in Stocks #29206
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Share Price
$2.77
Market Cap
$22.40M
Change (1 day)
-0.93%
Change (1 year)
-17.48%
Country
JP
Trade Kringle Pharma, Inc. (4884)

Category

Earnings for Kringle Pharma, Inc. (4884)
Earnings in 2026 TTM: 0
According to Kringle Pharma, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Kringle Pharma, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$1.61B -
AU
- -
CH